Literature DB >> 25944883

Novel Host Proteins and Signaling Pathways in Enteropathogenic E. coli Pathogenesis Identified by Global Phosphoproteome Analysis.

Roland Scholz1, Koshi Imami2, Nichollas E Scott2, William S Trimble3, Leonard J Foster4, B Brett Finlay5.   

Abstract

Enteropathogenic Escherichia coli (EPEC) uses a type III secretion system (T3SS) to directly translocate effector proteins into host cells where they play a pivotal role in subverting host cell signaling needed for disease. However, our knowledge of how EPEC affects host protein phosphorylation is limited to a few individual protein studies. We employed a quantitative proteomics approach to globally map alterations in the host phosphoproteome during EPEC infection. By characterizing host phosphorylation events at various time points throughout infection, we examined how EPEC dynamically impacts the host phosphoproteome over time. This experimental setup also enabled identification of T3SS-dependent and -independent changes in host phosphorylation. Specifically, T3SS-regulated events affected various cellular processes that are known EPEC targets, including cytoskeletal organization, immune signaling, and intracellular trafficking. However, the involvement of phosphorylation in these events has thus far been poorly studied. We confirmed the MAPK family as an established key host player, showed its central role in signal transduction during EPEC infection, and extended the repertoire of known signaling hubs with previously unrecognized proteins, including TPD52, CIN85, EPHA2, and HSP27. We identified altered phosphorylation of known EPEC targets, such as cofilin, where the involvement of phosphorylation has so far been undefined, thus providing novel mechanistic insights into the roles of these proteins in EPEC infection. An overlap of regulated proteins, especially those that are cytoskeleton-associated, was observed when compared with the phosphoproteome of Shigella-infected cells. We determined the biological relevance of the phosphorylation of a novel protein in EPEC pathogenesis, septin-9 (SEPT9). Both siRNA knockdown and a phosphorylation-impaired SEPT9 mutant decreased bacterial adherence and EPEC-mediated cell death. In contrast, a phosphorylation-mimicking SEPT9 mutant rescued these effects. Collectively, this study provides the first global analysis of phosphorylation-mediated processes during infection with an extracellular, diarrheagenic bacterial pathogen.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25944883      PMCID: PMC4587332          DOI: 10.1074/mcp.M114.046847

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  92 in total

Review 1.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Authors:  Alexander R C Wong; Jaclyn S Pearson; Michael D Bright; Diana Munera; Keith S Robinson; Sau Fung Lee; Gad Frankel; Elizabeth L Hartland
Journal:  Mol Microbiol       Date:  2011-05-05       Impact factor: 3.501

2.  A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton.

Authors:  P Aspenström
Journal:  Curr Biol       Date:  1997-07-01       Impact factor: 10.834

3.  Enteropathogenic Escherichia coli infection induces expression of the early growth response factor by activating mitogen-activated protein kinase cascades in epithelial cells.

Authors:  M de Grado; C M Rosenberger; A Gauthier; B A Vallance; B B Finlay
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Recruitment of cytoskeletal and signaling proteins to enteropathogenic and enterohemorrhagic Escherichia coli pedestals.

Authors:  D L Goosney; R DeVinney; B B Finlay
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells.

Authors:  S Gruenheid; R DeVinney; F Bladt; D Goosney; S Gelkop; G D Gish; T Pawson; B B Finlay
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

6.  Global impact of Salmonella pathogenicity island 2-secreted effectors on the host phosphoproteome.

Authors:  Koshi Imami; Amit P Bhavsar; Hongbing Yu; Nat F Brown; Lindsay D Rogers; B Brett Finlay; Leonard J Foster
Journal:  Mol Cell Proteomics       Date:  2013-03-03       Impact factor: 5.911

7.  Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins.

Authors:  D Stokoe; K Engel; D G Campbell; P Cohen; M Gaestel
Journal:  FEBS Lett       Date:  1992-11-30       Impact factor: 4.124

8.  Successive and selective release of phosphorylated peptides captured by hydroxy acid-modified metal oxide chromatography.

Authors:  Yutaka Kyono; Naoyuki Sugiyama; Koshi Imami; Masaru Tomita; Yasushi Ishihama
Journal:  J Proteome Res       Date:  2008-09-04       Impact factor: 4.466

Review 9.  Septins: the fourth component of the cytoskeleton.

Authors:  Serge Mostowy; Pascale Cossart
Journal:  Nat Rev Mol Cell Biol       Date:  2012-02-08       Impact factor: 94.444

Review 10.  Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes.

Authors:  Fernando Navarro-Garcia; Antonio Serapio-Palacios; Paul Ugalde-Silva; Gabriela Tapia-Pastrana; Lucia Chavez-Dueñas
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

View more
  16 in total

Review 1.  Modulation of host signaling in the inflammatory response by enteropathogenic Escherichia coli virulence proteins.

Authors:  Xiaonan Zhuang; Zijuan Chen; Chenxi He; Lin Wang; Ruixue Zhou; Dapeng Yan; Baoxue Ge
Journal:  Cell Mol Immunol       Date:  2016-10-31       Impact factor: 11.530

2.  Production and analysis of a mammalian septin hetero-octamer complex.

Authors:  Barry T DeRose; Robert S Kelley; Roshni Ravi; Bashkim Kokona; Joris Beld; Elias T Spiliotis; Shae B Padrick
Journal:  Cytoskeleton (Hoboken)       Date:  2020-11-23

3.  Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells.

Authors:  Louis Devlin; Joshua Okletey; George Perkins; Jonathan R Bowen; Konstantinos Nakos; Cristina Montagna; Elias T Spiliotis
Journal:  Proteomics       Date:  2021-08-31       Impact factor: 5.393

4.  Phospho-Network Analysis Identifies and Quantifies Hepatitis C Virus (HCV)-induced Hepatocellular Carcinoma (HCC) Proteins Regulating Viral-mediated Tumor Growth.

Authors:  Nu T Lu; Natalie M Liu; James Q Vu; Darshil Patel; Whitaker Cohn; Joe Capri; Mary Ziegler; Nikita Patel; Angela Tramontano; Roger Williams; Julian Whitelegge; Samuel W French
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

Review 5.  Cellular functions of actin- and microtubule-associated septins.

Authors:  Elias T Spiliotis; Konstantinos Nakos
Journal:  Curr Biol       Date:  2021-05-24       Impact factor: 10.900

Review 6.  Septins and Bacterial Infection.

Authors:  Vincenzo Torraca; Serge Mostowy
Journal:  Front Cell Dev Biol       Date:  2016-11-11

Review 7.  Sharpening Host Defenses during Infection: Proteases Cut to the Chase.

Authors:  Natalie C Marshall; B Brett Finlay; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2017-02-08       Impact factor: 5.911

8.  Mass Spectrometry Targeted Assays as a Tool to Improve Our Understanding of Post-translational Modifications in Pathogenic Bacteria.

Authors:  Nelson C Soares; Jonathan M Blackburn
Journal:  Front Microbiol       Date:  2016-08-04       Impact factor: 5.640

Review 9.  Elucidating Host-Pathogen Interactions Based on Post-Translational Modifications Using Proteomics Approaches.

Authors:  Vaishnavi Ravikumar; Carsten Jers; Ivan Mijakovic
Journal:  Front Microbiol       Date:  2015-11-20       Impact factor: 5.640

Review 10.  Proteomic discovery of host kinase signaling in bacterial infections.

Authors:  Erik Richter; Jörg Mostertz; Falko Hochgräfe
Journal:  Proteomics Clin Appl       Date:  2016-09-09       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.